This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Eoflow can continue to supply products to existing patients in South Korea and EU, Massachusetts federal court decides

( April 24, 2024, 15:25 GMT | Official Statement) -- MLex Summary: Eoflow has seen the US District of Masachusetts introducing carve-outs to allow the continued supply of its products to existing patients in South Korea and the EU under specific conditions. The order, published today, also permits Eoflow to complete clinical trials in the UAE and maintain regulatory certifications, provided it safeguards Insulet's trade secrets through confidentiality measures.Court order attached...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login